alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNITED STATES DISTRICT COURT

FOR THE 

DISTRICT OF ARIZONA

Reece Freeman,

Plaintiff,

v.

C. R. Bard Inc. and Bard Peripheral 

Vascular, Inc.,

Defendant.

)

)

)

)

)

)

)

)

)

MDL Case No. 2:15-md-02641-DGC

Civil Action No. CV-17-01526-PHX-DGC

WAIVER OF THE SERVICE OF SUMMONS

To: Wetherall Group, Ltd

(Name of plaintiff’s attorney or unrepresented plaintiff)

I have received your request to waive service of a summons in this action along with a copy of the complaint, two 

copies of this waiver form, and a prepaid means of returning one signed copy of the form to you.

I, or the entity I represent, agree to save the expense of serving a summons and complaint in this case.

I understand that I, or the entity I represent, will keep all defenses or objections to the lawsuit, the court’s 

jurisdiction, and the venue of the action, but that I waive any objections to the absence of a summons or of service.

I also understand that I, or the entity I represent, must file and serve an answer or a motion under Rule 12 within 

60 days from 10/20/2017, the date when this request was sent (or 90 days if it was sent outside the United States). If I fail 

to do so, a default judgment will be entered against me or the entity I represent.

Date: October 26, 2017 /s/ Richard B. North, Jr.

Signature of the attorney or unrepresented party

C. R. Bard, Inc. and Bard Peripheral

Vascular, Inc.

Printed name of parties waiving service of 

summons

Richard B. North, Jr. (Ga. Bar No. 545599)

Printed Name

Nelson Mullins Riley & Scarborough, LLP

201 17th St., NW, Suite 1700, Atlantic Station, Atlanta, GA 30363

Address

richard.north@nelsonmullins.com

E-mail Address

(404) 322-6155

Telephone number

Duty to Avoid Unnecessary Expenses of Serving a Summons

Rule 4 of the Federal Rules of Civil Procedure requires certain defendants to cooperate in saving unnecessary expenses of serving a 

summons and complaint. A defendant who is located in the United States and who fails to return a signed waiver of service requested by a plaintiff 

located in the United States will be required to pay the expenses of service, unless the defendant shows good cause for the failure. 

Case 2:15-md-02641-DGC Document 8534 Filed 11/02/17 Page 1 of 2
2

“Good cause” does not include a belief that the lawsuit is groundless, or that it has been brought in an improper venue, or that the court has 

no jurisdiction over this matter or over the defendant or the defendant’s property. 

If the waiver is signed and returned, you can still make these and all other defenses and objections, but you cannot object to the absence of 

a summons or of service. 

If you waive service, then you must, within the time specified on the waiver form, serve an answer or a motion under Rule 12 on the 

plaintiff and file a copy with the court. By signing and returning the waiver form, you are allowed more time to respond than if a summons had been 

served.

Case 2:15-md-02641-DGC Document 8534 Filed 11/02/17 Page 2 of 2
exv10w8



 



Exhibit 10.8


GANNETT CO., INC.



TRANSITIONAL COMPENSATION PLAN



Amendment dated December 3, 2002



     Pursuant to Section 17 of the Gannett Co., Inc. Transitional Compensation
Plan (the “Plan”), the Executive Compensation Committee of the Board of
Directors of Gannett Co., Inc. hereby amends the Plan as follows:


     Effective as of December 3, 2002, Section 7(b)(i) is amended by replacing
clause (C) with the following*:



		
	 	“(C) all compensation previously deferred by the Participant, accrued and
unpaid vacation pay and all other amounts to which the Participant is
entitled through the Date of Termination under any compensation or
benefit plan (other than amounts under the 1978 Executive Long Term
Incentive Plan, the 2001 Omnibus Incentive Compensation Plan, or any
comparable or successor plan (collectively, the “Incentive Compensation
Plan”), the Deferred Compensation Plan or any comparable or successor
plan, or the Company’s retirement and 401(k) Plans, payment under which
plans shall continue to be made in accordance with their terms) of the
Company;”
	 
	 	(*New language is underlined.)



     IN WITNESS WHEREOF, Gannett Co., Inc. has caused this amendment to be
executed by its duly authorized officer as of December 3, 2002.



	 	 	 
	GANNETT CO., INC.
	 
	By:

Name:

Title:	 	
/s/ Richard L. Clapp



Richard L. Clapp

Senior Vice President/

Human Resources
I

105TH CONGRESS

1ST SESSION H. R. 603

To prohibit Federal subsidies for the Tennessee Valley Authority after fiscal

year 1998.

IN THE HOUSE OF REPRESENTATIVES

FEBRUARY 5, 1997

Mr. FRANKS of New Jersey (for himself and Mr. MEEHAN) introduced the following bill; which was referred to the Committee on Transportation and

Infrastructure

A BILL

To prohibit Federal subsidies for the Tennessee Valley

Authority after fiscal year 1998.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Tennessee Valley Au5 thority First Step Reform Act of 1997’’.

6 SEC. 2. FINDINGS AND PURPOSES.

7 The Congress finds that:

8 (1) The Tennessee Valley Authority was estab9 lished in 1933 to, among other things, bring the
2

•HR 603 IH

1 benefits of electrification to an impoverished region

2 of America.

3 (2) The Tennessee Valley Authority has fulfilled

4 this mission and the once impoverished region enjoys

5 relative prosperity.

6 (3) To provide the benefits of electrification to

7 residents of the Tennessee Valley, the Federal Gov8 ernment provided the Tennessee Valley Authority

9 with an array of subsidies, including tax exemptions,

10 favorable treatments affecting the cost of capital,

11 and access to preference power, as well as relatively

12 minor appropriation subsidies associated with eco13 nomic development and waterway management.

14 (4) In the interest of deficit reduction, the

15 Chairman of the Tennessee Valley Authority is to be

16 commended for suggesting that appropriation sub17 sidies to Tennessee Valley Authority totaling some

18 $106,000,000 in fiscal year 1997, be phased out

19 over the next 2 years.

20 SEC. 3. DISCONTINUANCE OF APPROPRIATIONS.

21 Section 27 of the Tennessee Valley Authority Act of

22 1933 (16 U.S.C. 831z) is amended by inserting the follow23 ing before the period at the end thereof: ‘‘through the fis24 cal year 1998, but no funds may be appropriated for such

25 purposes for any fiscal year thereafter’’.
3

•HR 603 IH

1 SEC. 4. REPORTS.

2 (a) COST OF FEDERAL SUBSIDIES.—Not later than

3 January 1, 1998, the Director of the Office of Manage4 ment and Budget shall develop and submit a report to

5 Congress that describes and details the historical and cur6 rent costs to the Federal Government of subsidies pro7 vided to the Tennessee Valley Authority, including tax ex8 emptions, favorable treatments affecting the cost of cap9 ital, and access to preference power.

10 (b) TRANSITION PLAN.—Not later than January 1,

11 1998, the Director of the Office of Management and

12 Budget, after consultation with the Chairman of the Ten13 nessee Valley Authority and other appropriate persons,

14 shall develop and submit a plan to Congress outlining how

15 the Authority plans to make the transition from receiving

16 Federal subsidies to an organization generating, transmit17 ting and distributing electric power on an open and com18 petitive market.

Æ
Exhibit
32.2




YUHE
INTERNATIONAL, INC.




CERTIFICATION
PURSUANT TO




18 U.S.C.
SECTION 1350,




AS
ADOPTED PURSUANT TO SECTION 906




OF THE
SARBANES-OXLEY ACT OF 2002




In
connection with the Quarterly Report of YUHE INTERNATIONAL, INC. (the “Company”)
on Form 10-Q for the quarter ended September 30, 2010, as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Hu
Gang, the Chief Financial Officer of the Company, CERTIFY, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:




(1)   The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and




(2)     The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.




Date:
November 15, 2010





/s/
      Hu GangHu
      GangChief
      Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          OCT-31-1998
<PERIOD-START>                             OCT-26-1997
<PERIOD-END>                               MAY-02-1998
<CASH>                                           1,921
<SECURITIES>                                         0
<RECEIVABLES>                                   23,044
<ALLOWANCES>                                       138
<INVENTORY>                                     32,790
<CURRENT-ASSETS>                                62,412
<PP&E>                                          78,381
<DEPRECIATION>                                  43,538
<TOTAL-ASSETS>                                 283,335
<CURRENT-LIABILITIES>                           28,611
<BONDS>                                        229,731
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     (6,588)
<TOTAL-LIABILITY-AND-EQUITY>                   283,335
<SALES>                                         83,152
<TOTAL-REVENUES>                                85,835
<CGS>                                           52,560
<TOTAL-COSTS>                                   73,776
<OTHER-EXPENSES>                                 (216)
<LOSS-PROVISION>                                  (15)
<INTEREST-EXPENSE>                              11,337
<INCOME-PRETAX>                                    938
<INCOME-TAX>                                       477
<INCOME-CONTINUING>                                461
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       461
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
{"version":"1.0","provider_name":"NASA","provider_url":"https:\/\/www.nasa.gov","author_name":"NASA","author_url":"https:\/\/www.nasa.gov\/author\/nasamigrate\/","title":"NASA Administrator Hosts Crew-1 Astronauts, Exhibit on Capitol Hill","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"FRDvdf28qg\"><a href=\"https:\/\/www.nasa.gov\/news-release\/nasa-administrator-hosts-crew-1-astronauts-exhibit-on-capitol-hill\/\">NASA Administrator Hosts Crew-1 Astronauts, Exhibit on Capitol Hill<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.nasa.gov\/news-release\/nasa-administrator-hosts-crew-1-astronauts-exhibit-on-capitol-hill\/embed\/#?secret=FRDvdf28qg\" width=\"600\" height=\"338\" title=\"“NASA Administrator Hosts Crew-1 Astronauts, Exhibit on Capitol Hill” — NASA\" data-secret=\"FRDvdf28qg\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/www.nasa.gov\/wp-content\/uploads\/2021\/11\/crew-1.jpg?w=600","thumbnail_width":600,"thumbnail_height":366}
{"version":"1.0","provider_name":"NASA","provider_url":"https:\/\/www.nasa.gov","author_name":"Ana Guzman","author_url":"https:\/\/www.nasa.gov\/author\/ana-d-guzmannasa-gov\/","title":"15 Ways the International Space Station Benefits Humanity Back on Earth","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"mKcjDJmzjU\"><a href=\"https:\/\/www.nasa.gov\/missions\/station\/15-ways-the-international-space-station-benefits-humanity-back-on-earth\/\">15 Ways the International Space Station Benefits Humanity Back on Earth<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.nasa.gov\/missions\/station\/15-ways-the-international-space-station-benefits-humanity-back-on-earth\/embed\/#?secret=mKcjDJmzjU\" width=\"600\" height=\"338\" title=\"“15 Ways the International Space Station Benefits Humanity Back on Earth” — NASA\" data-secret=\"mKcjDJmzjU\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/images-assets.nasa.gov\/image\/s118e09418\/s118e09418~large.jpg?w=600&h=1307&fit=clip&crop=faces%2Cfocalpoint","thumbnail_width":600,"thumbnail_height":1307}
```

[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[H.R. 738 Introduced in House (IH)]

105th CONGRESS
  1st Session
                                H. R. 738

To amend the Federal Food, Drug, and Cosmetic Act and the Public Health 
      Service Act with respect to myelogram-related arachnoiditis.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 12, 1997

Mr. Traficant introduced the following bill; which was referred to the 
                         Committee on Commerce

_______________________________________________________________________

                                 A BILL

 
To amend the Federal Food, Drug, and Cosmetic Act and the Public Health 
      Service Act with respect to myelogram-related arachnoiditis.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Myelogram-Related Arachnoiditis 
Amendments of 1997''.

SEC. 2. ADULTERATED MYELOGRAMS.

    Section 501 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
351) is amended by adding at the end the following:
    ``(j) If it is a myelogram involving the use of Pantopaque, 
Amipaque, Omipacque, or Isovue.''.

SEC. 3. MYELOGRAM-RELATED ARACHNOIDITIS; ACTIVITIES OF NATIONAL 
              INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE.

    Subpart 10 of part C of title IV of the Public Health Service Act 
(42 U.S.C. 285j et seq.) is amended by adding at the end the following 
section:

                   ``myelogram-related arachnoiditis

    ``Sec. 460A. With respect to individuals who have undergone the 
diagnostic procedure known as a myelogram and who have subsequently 
developed cases of arachnoiditis, the Director of the Institute shall--
            ``(1) conduct or support a study to develop an estimate of 
        the number of such individuals in the United States;
            ``(2) conduct or support research to determine the extent 
        to which such cases are associated with the use of such 
        procedure; and
            ``(3) conduct or support research on treatments for such 
        cases in such individuals, including treatments to manage 
        pain.''.
                                 <all>
```
{"version":"1.0","provider_name":"NASA","provider_url":"https:\/\/www.nasa.gov","author_name":"NASA","author_url":"https:\/\/www.nasa.gov\/author\/nasamigrate\/","title":"What Is an Atomic Clock?","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"RhRF1h6uDA\"><a href=\"https:\/\/www.nasa.gov\/missions\/tech-demonstration\/deep-space-atomic-clock\/what-is-an-atomic-clock\/\">What Is an Atomic Clock?<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.nasa.gov\/missions\/tech-demonstration\/deep-space-atomic-clock\/what-is-an-atomic-clock\/embed\/#?secret=RhRF1h6uDA\" width=\"600\" height=\"338\" title=\"“What Is an Atomic Clock?” — NASA\" data-secret=\"RhRF1h6uDA\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n"}
Exhibit 31.1
 
 CERTIFICATION
 
 I, Barry Hertz, CEO of Track Data Corporation, certify that:1.
I have reviewed this annual report on Form 10-K of Track Data Corporation;2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:(a.)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;(b)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and(c)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 Date: March 19, 2004
/s/Barry Hertz, CEO(principal executive officer)
#### Stanley Mark BALLENGER, Plaintiff—Appellant, v. John BARKLEY, SCDC Inmate Service Coordinator, Defendant—Appellee.

No. 04-7888.

United States Court of Appeals, Fourth Circuit.

Submitted Feb. 18, 2005.

Decided March 11, 2005.

Stanley Mark Ballenger, Appellant pro se.

David Michael Tatarsky, South Carolina Department of Corrections, Columbia, South Carolina, for Appellee.

Before LUTTIG, WILLIAMS, and SHEDD, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).

PER CURIAM.

Stanley Mark Ballenger appeals the district court’s order accepting the recommendation of the magistrate judge and denying relief on his 42 U.S.C. § 1983 (2000) complaint. We have reviewed the record and find no reversible error. Accordingly, we affirm on the reasoning of the district court. *See Ballenger v. Barkley,*No. CA-03-3333-6-18AK (D.S.C. Nov. *11515, 2004). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED*

1